166 related articles for article (PubMed ID: 34056527)
1. Real-World Use of Azathioprine Metabolites Changes Clinical Management of Inflammatory Bowel Disease.
Wilson L; Tuson S; Yang L; Loomes D
J Can Assoc Gastroenterol; 2021 Jun; 4(3):101-109. PubMed ID: 34056527
[TBL] [Abstract][Full Text] [Related]
2. Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease.
Barnes A; Ooi SJ; Lynch KD; Parthasarathy N; Bishara M; Gounder M; Grafton R; Leach P; Bampton P; Sechi A; Ng W; Connor S; van Langenberg D; Mountifield R; Andrews JM
Dig Dis Sci; 2023 Mar; 68(3):889-896. PubMed ID: 35687221
[TBL] [Abstract][Full Text] [Related]
3. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X
Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052
[TBL] [Abstract][Full Text] [Related]
4. Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel disease.
Deben DS; Wong DR; van Bodegraven AA
Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1433-1444. PubMed ID: 35023443
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
Spencer E; Norris E; Williams C; Dubinsky MC
Inflamm Bowel Dis; 2019 Jan; 25(1):142-149. PubMed ID: 29920603
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
7. American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases.
Vande Casteele N; Herfarth H; Katz J; Falck-Ytter Y; Singh S
Gastroenterology; 2017 Sep; 153(3):835-857.e6. PubMed ID: 28774547
[TBL] [Abstract][Full Text] [Related]
8. Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.
Amin J; Huang B; Yoon J; Shih DQ
Inflamm Bowel Dis; 2015 Feb; 21(2):445-52. PubMed ID: 25248004
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease.
Carman N; Mack DR; Benchimol EI
Curr Gastroenterol Rep; 2018 Apr; 20(5):18. PubMed ID: 29623442
[TBL] [Abstract][Full Text] [Related]
10. Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients.
González-Lama Y; Bermejo F; López-Sanromán A; García-Sánchez V; Esteve M; Cabriada JL; McNicholl AG; Pajares R; Casellas F; Merino O; Carpio D; Vera MI; Muñoz C; Calvo M; Benito LM; Bujanda L; García-Fernández FJ; Ricart E; Ginard D; Velasco M; Carneros JA; Manceñido N; Calvo M; Algaba A; Froilan C; Cara C; Maté J; Abreu L; Gisbert JP;
Aliment Pharmacol Ther; 2011 Sep; 34(5):544-54. PubMed ID: 21722149
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.
Haines ML; Ajlouni Y; Irving PM; Sparrow MP; Rose R; Gearry RB; Gibson PR
Inflamm Bowel Dis; 2011 Jun; 17(6):1301-7. PubMed ID: 20812329
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring in patients with inflammatory bowel disease and established azathioprine therapy.
Gilissen LP; Derijks LJ; Bos LP; Bus PJ; Hooymans PM; Engels LG
Clin Drug Investig; 2004; 24(8):479-86. PubMed ID: 17523708
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine metabolite testing in inflammatory bowel disease.
Goldberg R; Moore G; Cunningham G; Schulberg J; Marsh P; Brown S; Connell W; Lust M; Kamm MA; Bell S
J Gastroenterol Hepatol; 2016 Mar; 31(3):553-60. PubMed ID: 26510636
[TBL] [Abstract][Full Text] [Related]
15. Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
Friedman AB; Brown SJ; Bampton P; Barclay ML; Chung A; Macrae FA; McKenzie J; Reynolds J; Gibson PR; Hanauer SB; Sparrow MP
Aliment Pharmacol Ther; 2018 Apr; 47(8):1092-1102. PubMed ID: 29468701
[TBL] [Abstract][Full Text] [Related]
16. Some cases demonstrating the clinical usefulness of therapeutic drug monitoring in thiopurine-treated inflammatory bowel disease patients.
Gilissen LP; Derijks LJ; Bos LP; Verhoeven HM; Bus PJ; Hooymans PM; Engels LG
Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):705-10. PubMed ID: 15201586
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA
J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
[TBL] [Abstract][Full Text] [Related]
18. New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
Khan A; Berahmana AB; Day AS; Barclay ML; Schultz M
N Z Med J; 2019 Mar; 132(1491):46-62. PubMed ID: 30845128
[TBL] [Abstract][Full Text] [Related]
19. The role of thiopurine metabolites in inflammatory bowel disease and rheumatological disorders.
Friedman AB; Sparrow MP; Gibson PR
Int J Rheum Dis; 2014 Feb; 17(2):132-41. PubMed ID: 24618304
[TBL] [Abstract][Full Text] [Related]
20. Azathioprine dosing and metabolite measurement in pediatric inflammatory bowel disease: does one size fit all?
Walker R; Kammermeier J; Vora R; Mutalib M
Ann Gastroenterol; 2019; 32(4):387-391. PubMed ID: 31263361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
